So the "step change in coverage" was a *correction* - they were under-reporting previously PB explained:
Previously they were looking at the top 5 payors in each state (as that would get them to 80% on a state-by-state basis, I assume)
They have recently realised that the "small change" (niche) insurers add up to a significant sum, which changes the story. When they recalculated the coverage using data from ALL insurers, they found WOW we have 255 million covered lives.
Also I would comment on the "80% critical mass"
This is basically a consensus estimate of how many patients need to be covered in order to convince the hospital/clinic accountants that it will be clearly profitable to offer SOZO services. It is part of the sales pitch to the hospitals.
So really, California being at 77% is close enough! The IPD sales reps don't really need to wait for another California payor to update their policy. The financial modelling will be pretty rosy already.
- Forums
- ASX - By Stock
- IPD
- Ann: 2024 AGM - CEO's Presentation
IPD
impedimed limited
Add to My Watchlist
13.8%
!
3.3¢

Ann: 2024 AGM - CEO's Presentation, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.3¢ |
Change
0.004(13.8%) |
Mkt cap ! $66.90M |
Open | High | Low | Value | Volume |
3.0¢ | 3.3¢ | 2.9¢ | $108.8K | 3.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 1063 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.030 |
3 | 1445672 | 0.029 |
3 | 187894 | 0.028 |
5 | 635000 | 0.027 |
5 | 1619829 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 1063 | 1 |
0.034 | 123000 | 1 |
0.035 | 335714 | 2 |
0.036 | 250000 | 1 |
0.037 | 100000 | 1 |
Last trade - 16.19pm 27/06/2025 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online